{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:52:15Z","timestamp":1789519935341,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN 263201600085U"],"award-info":[{"award-number":["HHSN 263201600085U"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 U24 OD023121"],"award-info":[{"award-number":["1 U24 OD023121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3 OT2 OD023205"],"award-info":[{"award-number":["3 OT2 OD023205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 OT2 OD025277"],"award-info":[{"award-number":["1 OT2 OD025277"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AOD 16037"],"award-info":[{"award-number":["AOD 16037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 OD023176"],"award-info":[{"award-number":["U24 OD023176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3 OT2 OD023206"],"award-info":[{"award-number":["3 OT2 OD023206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 OT2 OD026555"],"award-info":[{"award-number":["1 OT2 OD026555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 OT2 OD025276"],"award-info":[{"award-number":["1 OT2 OD025276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 U24 OD023163"],"award-info":[{"award-number":["1 U24 OD023163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.atherosclerosis.2026.120794","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:08:34Z","timestamp":1781140114000},"page":"120794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program"],"prefix":"10.1016","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-3894","authenticated-orcid":false,"given":"Yakubu","family":"Bene-Alhasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soad","family":"Al Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2538-6172","authenticated-orcid":false,"given":"Yussif","family":"Issaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ato","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Osei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120794_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke Statistics\u20142020 update: a report from the American heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib2","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib3","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001423","article-title":"ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","author":"Writing","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14797\/mdcvj.1670","article-title":"Population-Level gaps in coronary artery disease care: a focused review","volume":"21","author":"Kainat","year":"2025","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2022.100570","article-title":"The all of Us Research Program: data quality, utility, and diversity","volume":"3","author":"Ramirez","year":"2022","journal-title":"Patterns"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib7","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association declaration of helsinki: ethical principles for Medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1136\/amiajnl-2012-000896","article-title":"Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network","volume":"20","author":"Newton","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2026.103012","article-title":"Socioeconomic correlates of incident heart failure and consequent mortality: the all of Us Program","author":"Bene-Alhasan","year":"2026","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib10","doi-asserted-by":"crossref","unstructured":"Heiss A. Exploring R2 and regression variance with Euler\/Venn diagrams. Andrew Heiss. Available at: https:\/\/www.andrewheiss.com\/blog\/2021\/08\/21\/r2-euler\/. Accessed January 12, 2026.","DOI":"10.59350\/rx2cy-8eg45"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib11","author":"Larsson"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-Wide cross-sectional observational Study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib14","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American college of Cardiology\/American Heart Association task force on clinical practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib15","article-title":"Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA\/ACC multi-society cholesterol guideline","volume":"21","author":"Alanaeme","year":"2022","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib16","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"ODYSSEY OUTCOMES committees and investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER Steering Committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.22713","article-title":"PCSK9 inhibitor access barriers-issues and recommendations: improving the access process for patients, clinicians and payers","volume":"40","author":"Baum","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib19","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1358863X20957091","article-title":"Lipid-lowering therapies in peripheral artery disease: a review","volume":"26","author":"Skeik","year":"2021","journal-title":"Vasc Med Lond Engl"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib21","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/s41598-025-88516-0","article-title":"Differences in risk factor profiles for peripheral artery disease compared to coronary, cerebral and carotid artery","volume":"15","author":"Acosta","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-Dose atorvastatin after stroke or transient ischemic attack","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.122.009787","article-title":"Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort Study of 322 153 patients","volume":"16","author":"Navar","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-025-09472-z","article-title":"Physician perceptions, knowledge, and Implementation of Lipid-Lowering Guidelines in the USA","author":"Karmarkar","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11883-025-01275-1","article-title":"Lipid lowering therapy utilization and lipid goal attainment in women","volume":"27","author":"van Oortmerssen","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib28","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"EUROASPIRE Investigators\u2217. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-200000004-00001","article-title":"Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease","volume":"35","author":"Esler","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2026.120794_bib32","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2600283","article-title":"Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease","volume":"394","author":"Lee","year":"2026","journal-title":"N Engl J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:36:26Z","timestamp":1783028186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S0021915026001607"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120794","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120794"}}